BlackRock Advisors’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$126K Buy
5,598
+278
+5% +$6.71K ﹤0.01% 2928
2016
Q3
$122K Buy
5,320
+505
+10% +$11.3K ﹤0.01% 2928
2016
Q2
$103K Sell
4,815
-1,213
-20% -$38.2K ﹤0.01% 2950
2016
Q1
$207K Buy
6,028
+369
+7% +$9.75K ﹤0.01% 2532
2015
Q4
$156K Sell
5,659
-2,630
-32% -$71.9K ﹤0.01% 2702
2015
Q3
$248K Buy
8,289
+267
+3% +$8.74K ﹤0.01% 2597
2015
Q2
$338K Buy
8,022
+7,935
+9,121% +$375K ﹤0.01% 2458
2015
Q1
$4K Buy
+87
New +$4.23K ﹤0.01% 3569

Other funds holding ATEX

BlackRock Advisors's ATEX Position: Q4 2016 in Review

BlackRock Advisors increased its Anterix (ATEX) stake by 5.2% in Q4 2016, buying an estimated $6.71K and bringing the position to 5,598 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #2928.

BlackRock Advisors first reported a position in ATEX in Q1 2015 and has held it in 8 quarters since. The position peaked at $338K in Q2 2015. 55 funds tracked by Wall St. Rank hold ATEX as of Q4 2016.

  • BlackRock Advisors held 5,598 shares of Anterix worth $126K as of Q4 2016.
  • BlackRock Advisors bought 278 Anterix shares in Q4 2016, an estimated $6.71K.
  • Anterix made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2928 holding.
  • BlackRock Advisors first reported a position in Anterix in Q1 2015 and has held it in 8 quarters since.
  • BlackRock Advisors's Anterix position peaked at $338K in Q2 2015.
  • 55 funds tracked by Wall St. Rank held Anterix as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.